Netherlands-based investment group Gilde Healthcare has finally closed its new Venture & Growth VI fund with committed funding of €740 million, well ahead of its origi
The environment for financing in the digital health sector may be lacklustre at present, but the deals continue to trickle through, and the latest crop is headed by a resp
CARGO Therapeutics has said it plans to offer around 18.8 million shares in the latest bid by a biotech to list on the Nasdaq, amid a desultory year for initial public off
Genetic medicine specialist Lexeo Therapeutics is the latest biotech to line up an initial public offering (IPO), aiming to raise around $100 million from the transaction.
Biotech investment may be somewhat in the doldrums at the moment, but the sector continues to see a steady stream of deals – particularly in the venture capital category –
Life sciences venture capital company Sofinnova has doubled down on its strategy to expand into digital medicine, closing its first dedicated fund for the category with $2